New Anticoagulants for Stroke Prevention in Atrial Fibrillation

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
Christian Ruff, MD, MPH, of Harvard Medical School, gives an overview of the anticoagulants currently available for prevention of stroke in patients with atrial fibrillation.

Related Articles
Pharmacists must be aware that edoxaban should not be used in any patient with a creatinine clearance >95 ml/min.
Non-vitamin K antagonist oral anticoagulants are increasingly being prescribed to prevent and treat venous thromboembolism and avert stroke in patients with atrial fibrillation.
Is there a need to strengthen the labeling of topical NSAIDs that clearly lack systemic therapeutic or toxic levels?
Six patient deaths and other serious adverse events have been linked to SentreHeart’s Lariat Suture Delivery Device, the FDA is warning health care professionals.
Latest Issues
$auto_registration$